{
    "title": "Perceptions of Physicians on the Combination of Pantoprazole + Domperidone vs Pantoprazole Monotherapy in GERD Management",
    "questions": [
        {
            "id": 1,
            "question": "Approximately, what percentage of patients with symptoms of GERD do you encounter and manage every month?",
            "options": [
                "Less than 10% GERD patients/month",
                "10 – 30% GERD patients/month",
                "30 – 50% GERD patients/month",
                "More than 50% GERD patients/month"
            ]
        },
        {
            "id": 2,
            "question": "Which of the following clinical criteria do you most commonly prefer to diagnose GERD?",
            "options": [
                "Patient-reported symptoms (e.g., heartburn, regurgitation)",
                "Endoscopy findings",
                "Empirical trial of PPI therapy",
                "I use all of the above, depending on the case"
            ]
        },
        {
            "id": 3,
            "question": "Which class of medication do you most frequently initiate as first-line therapy for GERD?",
            "options": [
                "PPI",
                "PPI + Prokinetic",
                "H2 Receptor Antagonists",
                "Antacids/Alginates"
            ]
        },
        {
            "id": 4,
            "question": "Kindly rate the frequency of the following symptoms you encounter in your patients with GERD.",
            "symptoms": [
                "Heartburn",
                "LPR (Laryngopharyngeal Reflux)",
                "Chronic cough",
                "Dental erosion/damage",
                "Halitosis (bad breath)"
            ],
            "options": [
                "Frequently",
                "Occasionally",
                "Rarely"
            ]
        },
        {
            "id": 5,
            "question": "In your clinical practice, which drug class do you find most likely to cause GERD symptoms in patients?",
            "options": [
                "NSAIDs",
                "Heart medication",
                "Diabetes medication",
                "Corticosteroids",
                "Antibiotics"
            ]
        },
        {
            "id": 6,
            "question": "What percentage of your GERD patients, in your clinical experience, achieve adequate symptom resolution with PPI monotherapy?",
            "options": [
                "Less than 25% (PPI monotherapy is not sufficient)",
                "25% to 50%",
                "50% to 75%",
                "More than 75% (PPI monotherapy is sufficient)"
            ]
        },
        {
            "id": 7,
            "question": "What is the primary reason you prefer to add a prokinetic such as domperidone to a PPI-based GERD therapy?",
            "options": [
                "To address dyspeptic symptoms like bloating and early satiety",
                "To enhance the efficacy of the PPI by improving gastric emptying",
                "To manage nocturnal GERD symptoms or improve LES functioning",
                "To reduce the need for higher PPI doses",
                "All of the above"
            ]
        },
        {
            "id": 8,
            "question": "How frequently do you prefer to prescribe a combination of pantoprazole + domperidone for GERD patients in your clinical practice?",
            "options": [
                "Very Frequently (in more than 75% of GERD cases)",
                "Frequently (in 50-75% of GERD cases)",
                "Occasionally (in 25-50% of GERD cases)",
                "Not often (in less than 25% cases)"
            ]
        },
        {
            "id": 9,
            "question": "In which patient profile do you consider the pantoprazole + domperidone combination to be most clinically beneficial?",
            "options": [
                "Patients with classic GERD symptoms (heartburn, regurgitation)",
                "GERD patients who specifically have LES dysfunction or gastroparesis",
                "Patients who did not respond adequately to PPI monotherapy",
                "Patients requiring sustained, long-term control of GERD symptoms",
                "All of the above"
            ]
        },
        {
            "id": 10,
            "question": "What is your usual duration for prescribing Pantoprazole + Domperidone in GERD patients?",
            "options": [
                "Less than 4 weeks",
                "4–8 weeks",
                "8–12 weeks",
                "More than 6 months (long-term therapy)",
                "Tailored duration based on individual patient needs"
            ]
        },
        {
            "id": 11,
            "question": "Relative to PPI monotherapy, how would you rate the efficacy of the pantoprazole + domperidone combination in achieving symptom relief for GERD?",
            "options": [
                "Less effective than monotherapy",
                "Equally effective as monotherapy",
                "More effective than monotherapy",
                "Unsure/Can’t say"
            ]
        },
        {
            "id": 12,
            "question": "In your view, to what extent does the pantoprazole + domperidone combination improve patient quality of life compared to PPI monotherapy?",
            "options": [
                "Significantly improves quality of life compared with monotherapy",
                "Moderately improves quality of life compared with monotherapy",
                "Offers no significant improvement in quality of life compared with monotherapy"
            ]
        },
        {
            "id": 13,
            "question": "How does patient adherence to the pantoprazole + domperidone combination compare with a PPI monotherapy regimen?",
            "options": [
                "Adherence is lower with the combination",
                "Adherence is comparable between the combination and monotherapy",
                "Adherence is higher with the combination",
                "No significant difference in adherence between the two"
            ]
        },
        {
            "id": 14,
            "question": "Do you prefer a step-down therapy after discontinuing/withdrawing the current GERD treatment?",
            "options": [
                "Yes",
                "No"
            ],
            "follow_up": {
                "question": "If yes, which of the following do you usually prefer?",
                "options": [
                    "Pantoprazole 20 mg + Domperidone 10 mg",
                    "Pantoprazole 40 mg",
                    "Pantoprazole 20 mg",
                    "H2RA / Antacids"
                ]
            }
        },
        {
            "id": 15,
            "question": "In your clinical practice, what do you consider to be the most common causes of inadequate outcomes with PPI + prokinetic therapy in GERD patients?",
            "causes": [
                "Inappropriate adherence to prescribed dosage",
                "Incorrect timing of medication intake",
                "Premature discontinuation of therapy",
                "Need for escalation of therapy"
            ],
            "options": [
                "Highly Likely",
                "Likely",
                "Less Likely"
            ]
        }
    ]
}